17 results about "Glucose Injection" patented technology

The utility model relates to transfusion bottle technical field discloses a self -discharge formula glucose injection transfusion bottle bottle body, including bottle body and the pendant of fixed on bottle body, bottle body is by bottle body, bottle neck section and bottle mouth section is composed, the inner wall of bottle neck section is fixedly connected with the liquid lifting subassembly, the first envelope is equipped with in the bottle mouth section, the side wall of first envelope is fixedly connected with the support cover, one end of support cover and liquid lifting subassembly is through sliding arrangement. In the utility model, when only a small amount of glucose injection is left in the bottle body, the elasticity of the isolating sleeve makes the contraction sliding sleeve slide upward along the outer wall of the support cover, lifting the liquid level of the glucose injection in the bottle body, greatly reducing the residue of the glucose injection in the bottle body. By setting the protective cover, T-shaped column and the second through hole, the first envelope is protected and further fixed. The protective cover does not need to be removed when the infusion device needle is inserted.

The application discloses a method for detecting 5-hydroxymethylfurfural in a compatibility experiment of hydrocortisone sodium succinate for injection and glucose injection by HPLC. The 5-hydroxymethylfurfural is a degradation impurity of glucose. The detection method comprises the following steps: (1) preparation of a control sample solution; (2) preparation of a test sample solution; (3) chromatographic conditions; a mobile phase A is 8mmol / L potassium dihydrogen phosphate solution (pH value is adjusted to 5.0-5.1 by using 8mmol / L potassium hydrogen phosphate solution, and the solution is prepared freshly before use); a mobile phase B is methanol, gradient elution is carried out; a detection wavelength is 284nm; a column temperature is 40 DEG C; a flow rate is 1.4-1.6mL / min; and a chromatographic column is C 18 ; the application can effectively detect the content of 5-hydroxymethylfurfural, and has strong specificity and high sensitivity.

The utility model is suitable for liquid impurity detection technical field provides a kind of fluorine deoxy glucose injection's lamp detection device, including base;Through the pivot rotation installation in the adjusting plate of the base top;The illuminating lamp for emitting light to assist lamp detection is installed in the adjusting plate top;Through support rod fixed in the adjusting plate top and located the top plate of the illuminating lamp directly above, the top plate is fixed with the limiting piece for stabilizing fluorine deoxy glucose injection storage tube.This scheme provides fluorine deoxy glucose injection's lamp detection device by setting the observation board that can flexibly rotate, it is convenient to observe injection liquid light transmission shadow state from different angles, it is favorable to find impurity, while avoiding direct gaze light source by human eye, reduce the irritation to eye, make lamp detection process more comfortable.

The present application relates to the technical field of biology, and discloses a cell preservation solution, a preparation method and preparation thereof, and a cell preservation method. The cell preservation solution contains 1-10 mL compound electrolyte glucose injection, 1-10 mL human blood albumin injection, 1-10 mL compound amino acid injection, 10-20 uM salvianolic acid B, 20-60 uM rhodioside, and 1-10 uM ginkgo biloba bilobal, and the compound electrolyte injection is supplemented. The cell preservation solution can improve the biological activity of cells and prolong the preservation time of cells in multiple ways by adding traditional Chinese medicine extracts as antioxidants, membrane stabilizers and antithrombotics in response to the excess of free radicals in the low-temperature preservation process.

The utility model relates to the technical field of injection production, in particular to a production device for a pediatric compound electrolyte glucose injection. Comprising a reaction kettle and a feeding pipe body, a communicating groove is formed in one side of the reaction kettle, the communicating groove is fixedly connected with the feeding pipe body, connecting bases are fixedly arranged on the two sides of the feeding pipe body, a plurality of vertically-arranged connecting circular grooves are formed in the connecting bases, the connecting circular grooves communicate with the interior of the feeding pipe body, and feeding control plates are clamped to the inner sides of the connecting circular grooves; a plurality of electromagnetic valves are fixedly arranged on the feeding control plate, a sealing cylinder of a cylindrical structure is fixedly arranged at the other end of each electromagnetic valve, and the sealing cylinders are fastened and embedded into the connecting circular grooves. The utility model aims to solve the technical problems that in the production process of the traditional compound electrolyte glucose injection, single-pipeline batch feeding is usually adopted, the operation is tedious, and the productivity efficiency is restricted.

The invention relates to a CAR-NK (chimeric antigen receptor-natural killer) cell cryopreservation solution for clinical use as well as a preparation method and application thereof. The CAR-NK cell freezing medium disclosed by the invention is prepared from a washing solution, a dextran 40 glucose injection and Cryostat CS10, or is prepared from the washing solution, human serum albumin and Cryostat CS10; wherein the washing liquid is prepared from sodium chloride injection and human serum albumin. The cryopreservation liquid disclosed by the invention is used for cryopreserving CAR-NK cells, does not have the problem of cell agglomeration, and can effectively maintain the viability and vitality of the cells; the cryopreservation liquid is simple in component, is in a GMP level or a medicine level, can be directly infused back to a human body, is convenient to prepare and easy to prepare in a large scale, and saves the production and manufacturing cost.

The utility model relates to the technical field of injection packaging, in particular to a packaging structure for pediatric compound electrolyte glucose injection. Comprising a bottom plate and a top plate, the bottom plate and the top plate are both located in the packaging box, a plurality of containing grooves allowing injection containers to be embedded are formed between the bottom plate and the top plate, connecting tables are fixedly arranged on the two sides of the bottom plate, connecting holes are formed in the centers of the connecting tables, and the connecting holes are in threaded connection with limiting columns; spiral threads matched with the connecting holes are formed in the outer walls of the limiting columns, side plates are fixedly arranged on the two sides of the top plate, round holes corresponding to the connecting holes are formed in the center sides of the side plates, bearings are fixedly connected to the inner wall sides of the round holes, and the inner walls of the bearings are fixedly connected with the tops of the limiting columns. The technical problem to be solved by the utility model is as follows: when the injection container is protected by adopting mutually clamped buffer clamping plates, the bottle body is easy to shake and be damaged due to inertial impact when the mutually fastened buffer clamping plates are disassembled.

The invention relates to a freezing medium and a freezing method for universal CAR (chimeric antigen receptor) cells. The cryopreservation liquid comprises a compound electrolyte injection, a human serum albumin injection, a sodium chloride injection, a dextran 40 glucose injection, a glucose injection, dimethyl sulfoxide and trehalose. The cell cryopreservation process is deeply analyzed, the specific cell cryopreservation liquid and the cryopreservation method are designed, all the components of the cryopreservation liquid are synergistic, the cryopreservation liquid can adapt to the specific cooling process, cell damage in the cryopreservation process is effectively reduced, the activity of the cryopreserved cells is effectively kept, the cryopreservation liquid can be directly used for reinfusion of patients, a specific sectional programmed cooling program is adopted, and the cell cryopreservation process is simplified. The cell cryopreservation device can further adapt to different cryopreservation volumes, so that the cryopreservation effect is further improved, the survival rate of cells is effectively guaranteed, and the cryopreserved cells still keep good cell activity.

The invention discloses a disposable transfusion air filter and belongs to medical instruments. At present, air filtration of domestic infusion apparatuses generally adopts a membrane technology, and a satisfactory filtration effect on too fine foreign matters or bacteria and viruses is difficult to achieve. According to the disposable infusion air filter, air containing suspended solids (PM2.5, PM10, NO2, SO2, O3, CO, bacteria, viruses and the like) can enter a liquid medicine bottle after being humidified, adsorbed, precipitated and purified through filtration liquid (0.9% sodium chloride injection or 5% glucose injection), so that the medication safety of a patient is guaranteed at a higher level, and the blank of the project in China is filled up. The disposable infusion air filter is only used for filtering air entering a liquid medicine bottle during infusion, and a conventional infusion apparatus needs to be used in a matched mode during infusion. Technical characteristics are shown in Figure 1 in the specification.

The utility model relates to the technical field of deoxidized glucose injection bottle plugs, in particular to deoxidized glucose injection bottle plug press sealing equipment which comprises a supporting assembly and a box body, the box body is arranged at the upper end of the supporting assembly, a box door is movably installed on one side of the box body, a fixing cover is arranged at the upper end of the box body, and a press sealing mechanism is arranged at the upper end of the box body. A first transmission rod is arranged at the output end of the hydraulic assembly; a sliding plate is arranged at one end of the first transmission rod; a press-sealing assembly is arranged at the lower end of the sliding plate; a second transmission rod is arranged in the press-sealing assembly; an adjusting mechanism is arranged in the box body, a first limiting sleeve is arranged in the adjusting mechanism, a first threaded rod is arranged on the first limiting sleeve, a first sliding sleeve is arranged on the first threaded rod, a first limiting rod is arranged on one side of the first sliding sleeve, and a first turbine is arranged at the bottom end of the first threaded rod.

This utility model discloses an auxiliary squeezer for fat emulsion amino acid glucose injection, including a main roller shaft, and a first pressure roller and a second pressure roller parallel to the main roller shaft. The end of the first pressure roller is connected to the end of the main roller shaft via a first connecting rod, and the end of the second pressure roller is connected to the end of the main roller shaft via a second connecting rod. At least one end of the second connecting rod is pivotally connected to the second connecting rod or the main roller shaft. The main roller shaft is provided with a groove matching the thickness of the injection bag, and the groove extends axially to form an elongated structure. This utility model provides an auxiliary squeezer for fat emulsion amino acid glucose injection, which can simulate the action of existing manual squeezing, squeezing the bag from the edge of the injection bag, which is conducive to the rapid peeling of the seal between the chambers. At the same time, the fingers of the medical staff are not squeezed, thus protecting the fingers of the medical staff.

The invention relates to the technical field of living body fluorescence tomography, and particularly discloses a weak fluorescence signal acquisition method which comprises the following steps: S1, firstly, fixing each structure in an axis limiting groove; then an electric push rod is started to push a center plate to move upwards to the highest position, anesthetic and fluoro-18 deoxyglucose injection is injected into the test mouse to be fixed to the center position of the center plate, and then the positions of a fluorescent CCD, an optical filter, an optical CCD and a laser are changed to be aligned to the test mouse; a side fixing plate, a top plate and a connecting film are all made of light-proof materials and are designed to be in a shading structure, a rotating motor is matched to drive a rotating table, an electric push rod, a guide rod and a center plate to rotate intermittently, a fluorescent CCD and an optical CCD are matched to take 36 pictures in a surrounding mode, all-directional fluorescent signals of a test mouse can be accurately captured, and the detection accuracy is improved. A three-dimensional model is formed by matching with modeling software, so that fluorescence signals on a test mouse body can be captured in all directions, and three-dimensional modeling recording is carried out.

The invention discloses a preparation method of eyedrops for preventing eye injury, and belongs to the technical field of eyedrops, the eyedrops are prepared by taking rhizoma polygonati, herba houttuyniae, sodium chloride, ethylparaben, distilled water and hypertonic liquid as raw materials, and the hypertonic liquid prepared by mixing glucose injection and vitamin C injection in the eyedrops has a dehydration effect in the application process, so that the eye injury can be prevented. The corneal edema can be quickly eliminated, the dehydration of corneal tissues is promoted, and the normal thickness is recovered, so that the vision is quickly recovered, the damage of corneal endothelium is furthest reduced, the corneal edema in the treatment process is effectively reduced, and the probability of cataract is further reduced; according to the traditional Chinese medicine eye drop, the components of rhizoma polygonati and herba houttuyniae are added, so that the eye drop has antibacterial and antiviral effects, rhizoma polygonati polysaccharide contained in rhizoma polygonati has the effects of increasing tear secretion and promoting ocular surface healing, dry eyes, foreign body sensation and burning sensation are improved, and the eye drop has no obvious irritation to cornea and iris and is suitable for different people.

The invention discloses a GLUT1 glucose injection device for sepsis cardiomyopathy, and relates to the technical field of injection devices.The GLUT1 glucose injection device comprises a main body mechanism, the main body mechanism comprises a shell, a controller is fixedly connected to one side of the shell, and two positioning plates are fixedly connected to the top of the shell; the GLUT1 glucose injection device comprises two positioning plates, the inner walls of the two positioning plates are fixedly connected with damping rotating shafts, the rotating ends of the damping rotating shafts are fixedly connected with positioning hooks, and one sides of the two positioning hooks are jointly and fixedly connected with a transparent cover. A plurality of injection barrels can be installed at a time, automatic switching and butt joint of the injection barrels and independent setting of parameters of the injection barrels are achieved, the injection precision of a glucose solution is guaranteed, meanwhile, the working difficulty of medical workers is lowered, the continuity and timeliness of injection are guaranteed, simultaneous working of a plurality of injection pumps is avoided, and the working efficiency is improved. Therefore, the space is saved.

This invention relates to an injectable paclitaxel formulation designed to enhance solubility and stability. The formulation comprises paclitaxel at a concentration of 6 to 12 mg / mL, with Vitamin E Polyethylene Glycol Succinate (TPGS) serving as a surfactant and solubilizer in concentrations ranging from 300 mg / mL to 600 mg / mL. Polyethylene glycol 300 (PEG 300) acts as a stabilizer, and citric acid is included as a buffering agent, along with water for injection. The formulation is stable at room temperature for about 27 hours after dilution in infusion liquids such as 5% dextrose injection USP, 0.9% sodium chloride injection USP, 5% dextrose and 0.9% sodium chloride injection USP and 5% dextrose in Ringer's Injection solutions. The diluted formulation forms a nano micellar solution with micelles ranging from 10 to 100 nm in size, ensuring a stable and clear solution for intravenous administration of paclitaxel, thus improving safety and efficacy.

The utility model discloses a K type cross two-way interface for hardening treatment of esophageal and gastric fundus varicose veins, which relates to the technical field of pipe connecting components and comprises a first through pipe, a conversion cavity is arranged at one end of the first through pipe, a fourth through pipe is arranged at the other end of the conversion cavity, a second through pipe is arranged on one side of the conversion cavity, and a third through pipe is arranged on the other side of the second through pipe. A conversion plate is arranged in the conversion cavity and composed of a first gate plate, a second gate plate, a third gate plate and a fourth gate plate, the first gate plate and the fourth gate plate are oppositely arranged, the included angle between the second gate plate and the third gate plate is 90 degrees, and the included angle between the second gate plate and the fourth gate plate is 45 degrees. The included angle between the first gate plate and the second gate plate is 45 degrees. By arranging a series of structures, the lauromacrogol injection, the tissue glue injection and the 50% glucose injection can be respectively injected without pulling and inserting the liquid injection tube, so that the liquid medicine injection efficiency is improved, and the leakage risk is reduced.

The utility model provides a sampling device for production of deoxidized glucose injection, which comprises a supporting stand column, a sampling device body, a sampling device main body, a sampling device main body, a sampling device main body and a sampling device main body, and is characterized in that a driving motor is fixed at the upper end of the supporting stand column; the mixed reaction barrel is located on the front side of the supporting stand column, the mixed reaction barrel is fixed to the surface of a fixed plate block, and the fixed plate block is connected with the supporting stand column through a movable block; the liquid conveying pipelines are positioned on the left and right sides of the mixed reaction barrel, and the middle parts of the liquid conveying pipelines are connected with micro superchargers; the liquid storage pipe is located at the lower end of the fixing plate, and a liquid taking needle is installed at the lower end of the liquid storage pipe. The device solves the problems that detection liquid has certain corrosion and dangerousness, the safety of sampling personnel is easily harmed because the detection liquid is generally extracted one by one manually during sampling analysis, and the deoxidized glucose injection cannot be detected by mechanical sampling instead of manual sampling.